RNA Manufacturing Resources

  1. Navigating Challenges In Progressing Breakthrough RNA Therapeutics 5/14/2024

    RNA therapeutics hold immense promise for precision treatment, but their development faces challenges. A CDMO with adaptable platforms and flexible timelines can help reduce time and costs.

  2. Genetic Engineering Medium Aiding The Transfection Of MSCs With siRNA 8/10/2023

    A newly developed genetic engineering medium is fueling the development of cell- and extracellular vesicle-based therapies.

  3. Current And Emerging Technologies To Optimize mRNA Manufacturing

    Explore the benefits of using mRNA for vaccines and therapeutics, and learn how to address technical, intellectual property, and cost considerations when considering commercial production.

  4. Comparing Process Development Approaches For Recombinant Proteins 2/26/2026

    Explore how adding a traceless tag enables streamlined affinity purification for recombinant proteins, and how this approach compares with a conventional process in development time, recovery, and purity.

  5. GMP Manufacturing Facility For Viral Vector Production 3/27/2018

    A new GMP production facility for viral vectors from nonadherent cell cultures alleviates concerns that there will be a restriction of speed in getting viral vector products from the laboratory to the patient.

  6. Research-Scale Oligonucleotide Workflow 10/30/2025

    Get a clear view of oligonucleotide development from synthesis to purification and filtration with practical insights to help you streamline workflows and stay ahead in the fight against disease.

  7. Sample Quality Control In Next-Generation Sequencing Workflows 3/4/2026

    See how automated electrophoresis and key integrity metrics strengthen NGS workflows by improving sample assessment, streamlining QC steps, and supporting confident decisions.

  8. Addressing The Challenges Of Late-Stage Aseptic Manufacturing 10/15/2024

    Gain insight into the current landscape of filling and late-stage manufacturing from a survey of 78 professionals from top companies in the industry.

  9. Where Can Novel Non-Viral Polymeric Delivery Agents Take Us? 1/18/2023

    Explore ongoing work to harness different types of HDR templates in order to build cutting-edge systems with the potential to enable point-of-care cell and gene therapy manufacture.

  10. A Proven Platform For Solid-Phase Oligonucleotide Synthesis 5/25/2022

    Facilitating oligonucleotide synthesis with state-of-the-art equipment and process support is critical to maximizing oligo production and achieving consistency at scale.